High affinity interactions and signal transduction between Aβ oligomers and TREM2
暂无分享,去创建一个
D. Holtzman | M. Colonna | T. Golde | P. Cruz | J. Ulrich | Thomas E Mahan | Yong Ran | Samuel L Malnik | Thomas B. Ladd | C. Lessard | Yingyue Zhou | Paramita Chakrabaty | Samuel L. Malnik
[1] M. Colonna,et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism , 2018, The Journal of experimental medicine.
[2] D. Holtzman,et al. Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal , 2017, Human molecular genetics.
[3] C. Haass,et al. An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function , 2017, EMBO molecular medicine.
[4] P. S. St George-Hyslop,et al. TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant , 2017, EMBO molecular medicine.
[5] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[6] D. Kober,et al. TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.
[7] David V. Hansen,et al. TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.
[8] R. Tanzi,et al. Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation , 2017, Alzheimer's & Dementia.
[9] Adrian Danek,et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury , 2016, Science Translational Medicine.
[10] Asha A. Nair,et al. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression , 2016, Alzheimer's & Dementia.
[11] Carlos Cruchaga,et al. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms , 2016, eLife.
[12] J. Grutzendler,et al. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.
[13] Lino C. Gonzalez,et al. TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.
[14] D. Holtzman,et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.
[15] L. Tan,et al. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese , 2016, Neurobiology of Aging.
[16] M. Colonna,et al. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis , 2016, Nature Reviews Neuroscience.
[17] D. Holtzman,et al. TREM2 Function in Alzheimer's Disease and Neurodegeneration. , 2016, ACS chemical neuroscience.
[18] D. Rujescu,et al. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease , 2015, Alzheimer's & Dementia.
[19] S. Younkin,et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.
[20] M. Farzan,et al. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.
[21] R. Tanzi. TREM2 and Risk of Alzheimer's Disease--Friend or Foe? , 2015, The New England journal of medicine.
[22] D. Holtzman,et al. Three dimensions of the amyloid hypothesis: time, space and 'wingmen' , 2015, Nature Neuroscience.
[23] S. Lincoln,et al. TREM2 is associated with increased risk for Alzheimer’s disease in African Americans , 2015, Molecular Neurodegeneration.
[24] R. Ransohoff,et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.
[25] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[26] Nathan D. Price,et al. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.
[27] L. Tan,et al. Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease , 2014, Neuropsychopharmacology.
[28] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[29] A. Goate,et al. Coding variants in TREM2 increase risk for Alzheimer's disease. , 2014, Human molecular genetics.
[30] D. Holtzman,et al. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 , 2014, Molecular Neurodegeneration.
[31] T. Golde,et al. γ-Secretase Processing and Effects of γ-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells* , 2013, The Journal of Biological Chemistry.
[32] H. Neumann,et al. Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.
[33] W. Streit,et al. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease , 2013, Alzheimer's Research & Therapy.
[34] Matthew H. Bailey,et al. GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease , 2013, Neuron.
[35] K. Coggeshall,et al. TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1 , 2010, Science Signaling.
[36] W. Seaman,et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.
[37] Kristina D. Micheva,et al. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.
[38] L. Peltonen,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts , 2005, Neurology.
[39] G. Krafft,et al. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.
[40] L. Peltonen,et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.
[41] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[42] O. Salonen,et al. CNS manifestations of Nasu–Hakola disease , 2001, Neurology.
[43] R. Ransohoff,et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. , 2016, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] Clemens F Kaminski,et al. Optical Super-Resolution Imaging of β-Amyloid Aggregation In Vitro and In Vivo: Method and Techniques. , 2016, Methods in molecular biology.
[45] L. Peltonen,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. , 2005, Neurology.
[46] L. Higgins,et al. A Transgenic Mouse Model of Alzheimer’s Disease , 1994 .